Related Articles
Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study
Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanoma
Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy
Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP‑Seq in neoadjuvant chemotherapy‑treated advanced ovarian cancer
Personalized circulating tumor DNA response to local radiotherapy in a patient with an early lobular breast cancer: A case report